JP2019520415A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520415A5
JP2019520415A5 JP2019500810A JP2019500810A JP2019520415A5 JP 2019520415 A5 JP2019520415 A5 JP 2019520415A5 JP 2019500810 A JP2019500810 A JP 2019500810A JP 2019500810 A JP2019500810 A JP 2019500810A JP 2019520415 A5 JP2019520415 A5 JP 2019520415A5
Authority
JP
Japan
Prior art keywords
quinoline
difluorophenyl
fluoro
aminopiperidin
methylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019500810A
Other languages
English (en)
Japanese (ja)
Other versions
JP6967577B2 (ja
JP2019520415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/041694 external-priority patent/WO2018013676A1/en
Publication of JP2019520415A publication Critical patent/JP2019520415A/ja
Publication of JP2019520415A5 publication Critical patent/JP2019520415A5/ja
Priority to JP2021173304A priority Critical patent/JP2022028675A/ja
Application granted granted Critical
Publication of JP6967577B2 publication Critical patent/JP6967577B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019500810A 2016-07-14 2017-07-12 ソマトスタチンモジュレーターとその使用 Active JP6967577B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021173304A JP2022028675A (ja) 2016-07-14 2021-10-22 ソマトスタチンモジュレーターとその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662362493P 2016-07-14 2016-07-14
US62/362,493 2016-07-14
US201662411338P 2016-10-21 2016-10-21
US62/411,338 2016-10-21
PCT/US2017/041694 WO2018013676A1 (en) 2016-07-14 2017-07-12 Somatostatin modulators and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021173304A Division JP2022028675A (ja) 2016-07-14 2021-10-22 ソマトスタチンモジュレーターとその使用

Publications (3)

Publication Number Publication Date
JP2019520415A JP2019520415A (ja) 2019-07-18
JP2019520415A5 true JP2019520415A5 (cg-RX-API-DMAC7.html) 2021-09-30
JP6967577B2 JP6967577B2 (ja) 2021-11-17

Family

ID=60941935

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019500810A Active JP6967577B2 (ja) 2016-07-14 2017-07-12 ソマトスタチンモジュレーターとその使用
JP2021173304A Ceased JP2022028675A (ja) 2016-07-14 2021-10-22 ソマトスタチンモジュレーターとその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021173304A Ceased JP2022028675A (ja) 2016-07-14 2021-10-22 ソマトスタチンモジュレーターとその使用

Country Status (24)

Country Link
US (6) US9896432B2 (cg-RX-API-DMAC7.html)
EP (2) EP3484865B1 (cg-RX-API-DMAC7.html)
JP (2) JP6967577B2 (cg-RX-API-DMAC7.html)
KR (2) KR102324042B1 (cg-RX-API-DMAC7.html)
CN (2) CN115557929A (cg-RX-API-DMAC7.html)
AU (2) AU2017296392B2 (cg-RX-API-DMAC7.html)
CA (1) CA3030423A1 (cg-RX-API-DMAC7.html)
DK (1) DK3484865T3 (cg-RX-API-DMAC7.html)
ES (1) ES2931472T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20221279T1 (cg-RX-API-DMAC7.html)
HU (1) HUE060182T2 (cg-RX-API-DMAC7.html)
IL (1) IL264178B2 (cg-RX-API-DMAC7.html)
LT (1) LT3484865T (cg-RX-API-DMAC7.html)
MX (1) MX390120B (cg-RX-API-DMAC7.html)
NZ (1) NZ750174A (cg-RX-API-DMAC7.html)
PL (1) PL3484865T3 (cg-RX-API-DMAC7.html)
PT (1) PT3484865T (cg-RX-API-DMAC7.html)
RS (1) RS63776B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201900349VA (cg-RX-API-DMAC7.html)
SM (1) SMT202200465T1 (cg-RX-API-DMAC7.html)
TW (1) TWI789355B (cg-RX-API-DMAC7.html)
UA (1) UA125393C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018013676A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201900317B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63776B1 (sr) * 2016-07-14 2022-12-30 Crinetics Pharmaceuticals Inc Modulatori somatostatina i njihove upotrebe
KR20190121404A (ko) * 2017-03-16 2019-10-25 크리네틱스 파마슈티칼스, 인크. 소마토스타틴 조절제 및 이의 용도
US11028068B2 (en) 2017-07-25 2021-06-08 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
RS63387B1 (sr) * 2018-01-17 2022-08-31 Crinetics Pharmaceuticals Inc Postupak proizvodnje modulatora somatostatina
JP7365347B2 (ja) * 2018-02-12 2023-10-19 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンモジュレーターおよびその使用
EP3807248A4 (en) * 2018-05-29 2021-10-27 Council of Scientific and Industrial Research BICYCLIC TOPOISOMERASE I INHIBITOR COMPOUNDS, THEIR PREPARATION AND USE
US10696689B2 (en) 2018-09-18 2020-06-30 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
EP3999509A4 (en) 2019-07-17 2023-07-19 Crinetics Pharmaceuticals, Inc. Crystalline forms of somatostatin modulators
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途
MA66139B1 (fr) * 2020-09-09 2025-09-30 Crinetics Pharmaceuticals, Inc. Formulations d'un modulateur de somatostatine
US11773076B2 (en) 2021-02-17 2023-10-03 Crinetics Pharmaceuticals, Inc. Crystalline forms of a somatostatin modulator
WO2022251212A2 (en) * 2021-05-25 2022-12-01 Crinetics Pharmaceuticals, Inc. Uses of a somatostatin modulator for the treatment of disease
JP7784437B2 (ja) 2021-09-28 2025-12-11 デンカ株式会社 クロロプレン系ブロック共重合体、ラテックス、ラテックス組成物、及びゴム組成物
MX2024008598A (es) * 2022-01-11 2024-07-23 Crinetics Pharmaceuticals Inc Usos de un modulador de somatostatina para el tratamiento del sindrome carcinoide.
WO2023238112A1 (en) 2022-06-10 2023-12-14 Assia Chemical Industries Ltd. Solid state forms of paltusotine and process for preparation thereof
CR20250214A (es) * 2022-10-28 2025-08-22 Basecamp Bio Inc Agonistas del receptor 2 de somatostatina y sus usos
WO2024129614A1 (en) 2022-12-13 2024-06-20 Crinetics Pharmaceuticals, Inc. Somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof
US12208092B2 (en) 2023-03-28 2025-01-28 Crinetics Pharmaceuticals, Inc. Compositions and methods for administering paltusotine to patients with hepatic impairment
WO2025111318A1 (en) * 2023-11-22 2025-05-30 Crinetics Pharmaceuticals, Inc. Somatostatin subtype receptor 3 (sstr3) agonists and uses thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1035154A (en) 1910-05-16 1912-08-13 Ernest G Clark Machine for rectifying perforated music and masters.
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
AU2002352868A1 (en) 2001-11-27 2003-06-10 Merck & Co., Inc. 4-aminoquinoline compounds
KR100659428B1 (ko) 2002-02-04 2006-12-19 에프. 호프만-라 로슈 아게 Npy 길항제로서의 퀴놀린 유도체
US7767817B2 (en) 2003-09-05 2010-08-03 Binghe Wang Water soluble boronic acid fluorescent reporter compounds and methods of use thereof
WO2006017326A1 (en) * 2004-07-13 2006-02-16 Glaxo Group Limited Antibacterial agents
US20060183763A1 (en) 2004-12-31 2006-08-17 Pfizer Inc Novel pyrrolidyl derivatives of heteroaromatic compounds
US7563821B2 (en) 2005-12-05 2009-07-21 Xenoport, Inc. Levodopa prodrug mesylate, compositions thereof, and uses thereof
JP2009527562A (ja) 2006-02-21 2009-07-30 アムゲン インコーポレイティッド ホスホジエステラーゼ10阻害剤としてのシンノリン誘導体
AU2007223801A1 (en) 2006-03-08 2007-09-13 Amgen Inc. Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
US20090258853A1 (en) 2006-03-13 2009-10-15 Brian Eastman Somatostatin Agonists
AU2009289316A1 (en) 2008-09-02 2010-03-11 Novartis Ag Bicyclic kinase inhibitors
GB0818241D0 (en) * 2008-10-06 2008-11-12 Cancer Res Technology Compounds and their use
MX342879B (es) * 2010-07-30 2016-10-14 Oncotherapy Science Inc * Derivados de quinolina e inhibidores de cinasa de cremallera de leucina embrionica materna que los contienen.
EP2726465A1 (en) 2011-05-23 2014-05-07 Elan Pharmaceuticals Inc. Inhibitors of lrrk2 kinase activity
US8871756B2 (en) 2011-08-11 2014-10-28 Hoffmann-La Roche Inc. Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
DE102011113749A1 (de) 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
US20140228417A1 (en) 2011-10-05 2014-08-14 Mapi Pharma Ltd. Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids
US9630976B2 (en) 2012-07-03 2017-04-25 Ono Pharmaceutical Co., Ltd. Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes
CA2888485C (en) * 2012-10-16 2021-01-26 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of ror.gamma.t
DK3053916T3 (en) 2013-09-30 2019-04-15 Ono Pharmaceutical Co RELATIONSHIP WITH SOMATOSTATIN RECEPTOR AGONIST ACTIVITY AND PHARMACEUTICAL USE THEREOF
JO3805B1 (ar) 2013-10-10 2021-01-31 Araxes Pharma Llc مثبطات كراس جي12سي
EP3124487A1 (en) 2014-03-24 2017-02-01 Takeda Pharmaceutical Company Limited Heterocyclic compound
US10011600B2 (en) 2014-09-25 2018-07-03 Araxes Pharma Llc Methods and compositions for inhibition of Ras
US9957267B2 (en) 2015-07-01 2018-05-01 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
US9902703B2 (en) 2015-07-01 2018-02-27 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
MX385424B (es) 2015-12-17 2025-03-18 Merck Patent Gmbh Antagonistas policiclicos del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos en el tratamiento de trastornos inmunitarios.
MX2019000246A (es) 2016-07-07 2019-05-27 Plantex Ltd Formas en estado solido del dimesilato de palbociclib.
RS63776B1 (sr) * 2016-07-14 2022-12-30 Crinetics Pharmaceuticals Inc Modulatori somatostatina i njihove upotrebe
RS63387B1 (sr) 2018-01-17 2022-08-31 Crinetics Pharmaceuticals Inc Postupak proizvodnje modulatora somatostatina
US10696689B2 (en) 2018-09-18 2020-06-30 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
EP3999509A4 (en) 2019-07-17 2023-07-19 Crinetics Pharmaceuticals, Inc. Crystalline forms of somatostatin modulators
MA66139B1 (fr) 2020-09-09 2025-09-30 Crinetics Pharmaceuticals, Inc. Formulations d'un modulateur de somatostatine

Similar Documents

Publication Publication Date Title
JP2019520415A5 (cg-RX-API-DMAC7.html)
HRP20221279T1 (hr) Modulatori somatostatina i njihove uporabe
US9051310B2 (en) Nicotinamide derivative or salt thereof
KR101825543B1 (ko) 유기 광전자 소자 및 표시장치
JP2015502967A5 (cg-RX-API-DMAC7.html)
EP3041841B1 (en) Triazolopyridine compounds, compositions and methods of use thereof
EP3392236A1 (en) Method for producing aromatic amide derivative
US5843973A (en) Thiazolidinone compounds and composition for angina pectoris comprising the compounds as an active ingredient
JP3058945B2 (ja) N−(3,3−ジ置換アクリロイル)ピペラジン誘導体
JPH0770072A (ja) チオウレア誘導体
Das Generated Tables by BIVNOR
KR20250088869A (ko) 유기 광전자 소자용 조성물, 유기 광전자 소자 및 표시 장치
US20260008767A1 (en) Somatostatin modulators and uses thereof
Cee 3a roAi. 1937-1938
TW200418858A (en) Carbapenem derivatives
JPH08217765A (ja) チアゾリジノン化合物
EA040023B1 (ru) Модуляторы соматостатина и их применения
JP2006045153A (ja) カルバペネム誘導体を含有する医薬
JPH08176149A (ja) チアゾール誘導体
JP2004262923A (ja) カルバペネム誘導体